DMDs are an essential issue but are they the only issue in MS treatment?
Can J Neurol Sci
.
2013 May;40(3):276-7.
doi: 10.1017/s0317167100014177.
Authors
Saeed Shahbeigi
1
,
Joel Oger
Affiliation
1
UBC Hosptial, University of British Columbia Multiple Sclerosis Clinic and Neuro-Immunology Laboratory, Vancouver, British Columbia, Canada.
PMID:
23603158
DOI:
10.1017/s0317167100014177
No abstract available
Publication types
Editorial
Comment
MeSH terms
Disease Management*
Humans
Multiple Sclerosis / therapy*
Practice Guidelines as Topic*